| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 34042-85-8 | Sudoxicam |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | 1027102-49-3 | UGM-IN-2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 1044503-04-9 | Sudoterb HCl(LL3858) |
≥98% | | 询价 |
| 4 | 80-33-1 | Chlorfenson |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | 624-01-1 | 5-Oxodecanoic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 6 | 1026295-98-6 | HDAC-IN-6 |
≥98% | | 询价 |
| 7 | 1238944-56-3 | HDAC-IN-20 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 8 | 2316-26-9 | 3,4-Dimethoxycinnamic acid |
| 100mg | 询价 |
| 9 | 1884231-52-0 | HDAC8-IN-20a |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 10 | 6953-61-3 | HDAC8-IN-2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | 960374-59-8 | ONX-0914(PR-957) |
| | 询价 |
| 12 | 1239908-20-3 | MLN9708(Ixazomib citrate) |
| | 询价 |
| 13 | 2235382-05-3 | HDAC6 degrader 9c |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 1451042-19-5 | HDAC3-IN-T326 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 15 | 1451042-18-4 | HDAC3-IN-T247 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 675184-27-7 | HCV-371 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | 691852-36-5 | HCV-086 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 18 | 18997-39-2 | HC-3 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 19 | 312595-37-2 | HC103A |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 20 | 91216-38-5 | HC102A |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 21 | 1628291-95-1 | HC-070 |
≥98% | | 询价 |
| 22 | 883031-03-6 | HC-067047 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 23 | 7733-96-2 | HC-056456 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 24 | 18671-82-4 | HC 9016 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 25 | 1426544-54-8 | HBX28258 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 26 | 1426944-49-1 | HBX19818 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 27 | 865773-15-5 | PF-03084014 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 28 | 40114-84-9 | HBX |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 29 | 2056899-56-8 | HBT-O |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | 489408-02-8 | HBT1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 31 | 944547-46-0 | Mycro3 |
≥98% | | 询价 |
| 32 | 957011-15-3 | HBF-0259 |
≥98% | | 询价 |
| 33 | 890605-54-6 | Heclin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 1793063-59-8 | HEC72702 |
≥98% | | 询价 |
| 35 | 2697-85-0 | HE-2200 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 28507-02-0 | HE-2000 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 37 | 1382469-16-0 | HDP-Mimic C4 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 38 | 147751-31-3 | HDL376 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 39 | 85-86-9 | Sudan III |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 40 | 80037-86-1 | Succinylacetone pyrrole |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 41 | 51568-18-4 | Succinylacetone |
≥98% | | 询价 |
| 42 | 101496-69-9 | Succinimide,N-(5-(p-aminophenoxy)pentyl)- |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 43 | 304-55-2 | Succimer |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 44 | 251356-32-8 | SU9518 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 45 | 57-09-0 | Cetrimonium bromide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | 1055412-47-9 | SU5614 |
≥98% | | 询价 |
| 47 | 550999-74-1 | Encenicline HCl salt(EVP6124 MT4666) |
≥98% | | 询价 |
| 48 | 15966-93-5 | SU-5408 |
≥98% | | 询价 |
| 49 | 186610-89-9 | SU4984 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 50 | 5812-07-7 | SU-4312 |
≥98% | | 询价 |
| 51 | 184003-14-3 | SU-200 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 52 | 251356-45-3 | SU16f |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 53 | 155651-56-2 | Fce 28260 |
≥98% | | 询价 |
| 54 | 168835-82-3 | SU-1498 |
≥98% | | 询价 |
| 55 | 627908-92-3 | SU14813 |
≥98% | | 询价 |
| 56 | 12379-49-6 | SU-13197 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 57 | 688036-19-3 | SU-11752 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 58 | 326914-10-7 | SU11652 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 59 | 1799711-21-9 | dBET1 |
| 5mg, 10mg, 25mg | 询价 |
| 60 | 347396-82-1 | Ranibizumab |
| 1mg | 询价 |
m.cnreagent.com